PMPRB report shows increased plan costs, promising pharmaceutical innovation: expert

20 September 2023 - A recent report by the Patented Medicine Prices Review Board shows increased growth for private drug ...

Read more →

The Inflation Reduction Act and access to high cost cardiovascular therapies

20 September 2023 - On August 29, 2023, the Biden-Harris administration announced the first 10 drugs selected for Medicare price ...

Read more →

Medicare’s historic prescription drug price negotiations

20 September 2023 - On 29 August 2023, the Biden administration announced the first 10 drugs whose prices will be ...

Read more →

The problem of limited supply agreements for Medicare price negotiation

15 September 2023 - Pharmaceutical manufacturers charge high prices for their products during periods of market exclusivity that end when ...

Read more →

FDA’s final breakthrough devices guidance now includes technologies that address health disparities

15 September 2023 - Final guidance on the US FDA breakthrough device program includes new language noting that the program ...

Read more →

EMA recommends non-renewal of authorisation of multiple myeloma medicine Blenrep

15 September 2023 - The CHMP has recommended not renewing the conditional marketing authorisation for Blenrep (belantamab mafodotin), a medicine ...

Read more →

Inflation Reduction Act continues to lower out of pocket prescription drug costs for drugs with price increases above inflation

13 September 2023 - CMS announces savings for some people with Medicare on 34 Part B prescription drugs. ...

Read more →

Merck can’t sue over drug pricing plan, HHS tells court

13 September 2023 - Company isn’t primary manufacturer, administration argues. ...

Read more →

FDA proposes changes to key approval pathway for medical devices, five years after promising

12 September 2023 - Five years after promising to fix a flawed regulatory pathway widely used by medical device manufacturers, ...

Read more →

MHRA’s new International Recognition Procedure: how does it shape up?

12 September 2023 - The field of life sciences and medicine development has become increasingly global. Multinational firms must make informed ...

Read more →

The Inflation Reduction Act will lead to fewer new medicines

11 September 2023 - The impact of the Inflation Reduction Act on the biopharmaceutical industry is going to be substantial in ...

Read more →

Yale experts discuss impact of Medicare price negotiation legislation

11 September 2023 - Following the announcement of the 10 drugs for which Medicare is authorised to negotiate prices, Yale experts ...

Read more →

The 4 arguments you will hear against drug price negotiation

6 September 2023 - While government-negotiated prices will not take effect until 2026, the list of specific drugs makes this legislative ...

Read more →

Inflation Reduction Act may accelerate generic and biosimilar market entry, but questions remain around CMS guidance

5 September 2023 - Last week, the Centers for Medicare and Medicaid Services announced its selection of the first 10 prescription ...

Read more →

Astellas withdraws lawsuit after evading Medicare drug price negotiations

6 September 2023 - Astellas was so sure that one of its drugs was going to be selected as part ...

Read more →